Biochemical markers for CVD risk assessment
    1.
    发明公开
    Biochemical markers for CVD risk assessment 审中-公开
    CVD风险评估的生化指标

    公开(公告)号:EP2538223A3

    公开(公告)日:2013-04-24

    申请号:EP12185057.2

    申请日:2008-11-04

    摘要: A method of bioassay for the quantification of peptide fragments comprising a neo-epitope formed by cleavage of a protein of an atherosclerotic plaque by a proteinase, wherein the protein is decorin and said method comprises contacting a sample such as urine or serum with an antibody reactive with the neo-epitope and determining the level of binding of said immunological binding partner to peptide fragments in said sample. The assay is predictive of risk of cardiovascular disease events.

    摘要翻译: 一种用于定量包含通过蛋白酶切割动脉粥样硬化斑块的蛋白质而形成的新表位的肽片段的生物测定法,其中所述蛋白质是核心蛋白聚糖,并且所述方法包括使样品例如尿液或血清与抗体反应 与新表位结合,并测定所述免疫结合配偶体与所述样品中肽片段的结合水平。 该测定可预测心血管疾病事件的风险。

    Biochemical markers for CVD risk assessment
    3.
    发明公开
    Biochemical markers for CVD risk assessment 审中-公开
    CVD风险评估的生化指标

    公开(公告)号:EP2538221A2

    公开(公告)日:2012-12-26

    申请号:EP12185050.7

    申请日:2008-11-04

    摘要: A method of bioassay for the quantification of peptide fragments comprising a neo-epitope formed by cleavage of a protein of an atherosclerotic plaque by a proteinase, wherein the protein is versican and said method comprises contacting a sample such as urine or serum with an antibody reactive with the neo-epitope and determining the level of binding of said immunological binding partner to peptide fragments in said sample. The assay is predictive of risk of cardiovascular disease events.

    摘要翻译: 一种用于定量包含通过蛋白酶切割动脉粥样硬化斑块的蛋白质而形成的新表位的肽片段的生物测定的方法,其中所述蛋白质为多功能蛋白并且所述方法包括使样品如尿液或血清与抗体反应 与新表位结合,并测定所述免疫结合配偶体与所述样品中肽片段的结合水平。 该测定可预测心血管疾病事件的风险。

    Biochemical markers for CVD risk assessment
    6.
    发明公开
    Biochemical markers for CVD risk assessment 审中-公开
    CVD风险评估的生化指标

    公开(公告)号:EP2538222A3

    公开(公告)日:2013-04-24

    申请号:EP12185053.1

    申请日:2008-11-04

    摘要: A method of bioassay for the quantification of peptide fragments comprising a neo-epitope formed by cleavage of a protein of an atherosclerotic plaque by a proteinase, wherein the protein is CRP and said method comprises contacting a sample such as urine or serum with an antibody reactive with the neo-epitope and determining the level of binding of said immunological binding partner to peptide fragments in said sample. The assay is predictive of risk of cardiovascular disease events.

    摘要翻译: 一种用于定量包含通过蛋白酶切割动脉粥样硬化斑块的蛋白质而形成的新表位的肽片段的生物测定法,其中所述蛋白质是CRP并且所述方法包括使样品如尿液或血清与抗体反应 与新表位结合,并测定所述免疫结合配偶体与所述样品中肽片段的结合水平。 该测定可预测心血管疾病事件的风险。

    Biochemical markers for CVD risk assessment
    8.
    发明公开
    Biochemical markers for CVD risk assessment 审中-公开
    CVD风险评估的生化指标

    公开(公告)号:EP2538218A8

    公开(公告)日:2013-02-27

    申请号:EP12185056.4

    申请日:2008-11-04

    IPC分类号: G01N33/542 C12Q1/37 C07K14/47

    摘要: A method of bioassay for the quantification of peptide fragments comprising a neo-epitope formed by cleavage of a protein of an atherosclerotic plaque, wherein the protein is biglycan and said method comprises contacting a sample such as urine or serum with an antibody reactive with the neo-epitope and determining the level of binding of said immunological binding partner to peptide fragments in said sample. The assay is predictive of risk of cardiovascular disease events.

    摘要翻译: 一种用于定量包含通过切割动脉粥样硬化斑块的蛋白质形成的新表位的肽片段的生物测定法,其中所述蛋白质是双糖链蛋白聚糖,并且所述方法包括使样品例如尿液或血清与可与新霉素反应的抗体 并确定所述免疫结合配偶体与所述样品中的肽片段的结合水平。 该测定可预测心血管疾病事件的风险。